These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 10127575)

  • 21. Adverse drug reaction program using pharmacist and nurse monitors.
    Miwa LJ; Randall RJ
    Hosp Formul; 1986 Nov; 21(11):1140-3, 1146. PubMed ID: 10279322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concurrent antibiotic-use review in a small hospital.
    Kerns MP; Meyer GE
    Am J Hosp Pharm; 1986 Jun; 43(6):1476-8. PubMed ID: 3728483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meeting JCAHO drug usage evaluation requirements in a small hospital.
    Moline KA
    Hosp Pharm; 1990 May; 25(5):486-8, 492. PubMed ID: 10104827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unreported adverse drug reactions determined by screening physician orders for diphenhydramine.
    Fraterrigo CC; Estep JM; Palmer MA
    Hosp Pharm; 1981 Aug; 16(8):421-3, 426. PubMed ID: 10252375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Designing drug-usage evaluation to meet Joint Commission requirements.
    Peroutka JA
    Pharm Pract Manag Q; 1996 Jul; 16(2):26-35. PubMed ID: 10161608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The JCAHO Agenda for Change: what changes in pharmacy and P & T activities do you need to prepare for in 1994?
    Doherty EC
    Hosp Formul; 1994 Jan; 29(1):54-6, 58-60, 64 passim. PubMed ID: 10131267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The adverse drug reaction: a clinical opportunity for pharmacists.
    Miller JD
    Hosp Pharm; 1995 Sep; 30(9):769-73. PubMed ID: 10151281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Even in best-run centers, preventable medication errors lengthen LOS, increase costs.
    Health Care Cost Reengineering Rep; 1998 Oct; 3(10):149-51. PubMed ID: 10186033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal disease audit and drug usage evaluation for all patients.
    Champagne MP
    Hosp Pharm; 1992 Dec; 27(12):1065-7, 1072. PubMed ID: 10122509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integration of drug-usage evaluation with a quality assurance program.
    Carasiti ME; Lamb RE; Davio M
    Top Hosp Pharm Manage; 1991 Jul; 11(2):6-17. PubMed ID: 10128637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective dosage adjustment program in a geriatric population.
    Guharoy SR
    Top Hosp Pharm Manage; 1994 Apr; 14(1):67-72. PubMed ID: 10171827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of the pharmacy department in the prevention of adverse drug events: a survey of current practices.
    Lin B; Anderson LR
    Pharm Pract Manag Q; 1997 Apr; 17(1):10-6. PubMed ID: 10166240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can a multidisciplinary initiative to increase adverse drug reaction reporting work?
    Perkerson KA; Quercia RA; Goldman M; Goddu G; Coleman CI
    Conn Med; 2004 May; 68(5):281-4. PubMed ID: 15171264
    [No Abstract]   [Full Text] [Related]  

  • 34. [Safer drug handling in hospitals. A new task for the drug committee].
    Osterman PO; Gyllenspetz L; Hartvig P; Levol R; Rane A; Söderström A
    Lakartidningen; 1996 Oct; 93(44):3917-20. PubMed ID: 8965581
    [No Abstract]   [Full Text] [Related]  

  • 35. Computer-assisted concurrent antibiotic review in a community hospital.
    Scarafile PD; Campbell BD; Kilroy JE; Mathewson HO
    Am J Hosp Pharm; 1985 Feb; 42(2):313-5. PubMed ID: 3838416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medication safety program reduces adverse drug events in a community hospital.
    Cohen MM; Kimmel NL; Benage MK; Cox MJ; Sanders N; Spence D; Chen J
    Qual Saf Health Care; 2005 Jun; 14(3):169-74. PubMed ID: 15933311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacist clinical intervention program.
    Smith SR; Utterback CM; Parr DD; Waller DJ
    Top Hosp Pharm Manage; 1993 Jul; 13(2):1-15. PubMed ID: 10128810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. P & T Committee role in advocating rational therapeutics.
    Borreson R
    Hosp Formul; 1986 May; 21(5):590-8. PubMed ID: 10311625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of a personal computer to monitor adverse drug reactions.
    Schlicht JR; Fowler TJ
    Hosp Pharm; 1991 Jan; 26(1):23-6. PubMed ID: 10108661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computer-based support system for formulary decisions.
    Senthilkumaran K; Shatz SM; Kalies RF
    Am J Hosp Pharm; 1987 Jun; 44(6):1362-6. PubMed ID: 3618613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.